UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lifted by Arbor Capital Management Inc. ADV

Arbor Capital Management Inc. ADV boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,484 shares of the healthcare conglomerate’s stock after acquiring an additional 91 shares during the period. Arbor Capital Management Inc. ADV’s holdings in UnitedHealth Group were worth $1,335,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at approximately $30,000. Promus Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group during the 3rd quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter valued at approximately $40,000. 87.86% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research analysts have issued reports on UNH shares. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target for the company in a research report on Friday, January 10th. Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Finally, Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $629.32.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $488.52 on Monday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $446.85 billion, a price-to-earnings ratio of 31.52, a P/E/G ratio of 1.37 and a beta of 0.62. The stock’s fifty day simple moving average is $511.36 and its 200-day simple moving average is $549.80.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the company posted $5.83 earnings per share. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.72%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.